Financial Performance - The company's revenue for Q1 2025 was CNY 419,364,837.64, representing a 2.65% increase compared to CNY 408,557,558.49 in the same period last year[5] - Net profit attributable to shareholders decreased by 41.64% to CNY 20,880,674.01 from CNY 35,777,065.98 year-on-year[5] - The company's basic and diluted earnings per share decreased by 40.00% to CNY 0.18 from CNY 0.30 in the same period last year[5] - Net profit for the current period was ¥26,559,017.96, a decrease of 32.4% from ¥39,300,354.08 in the previous period[20] - The net profit attributable to the parent company was ¥20,880,674.01, down 41.6% from ¥35,777,065.98[20] Cash Flow - The net cash flow from operating activities increased significantly by 112.58% to CNY 49,593,799.82, up from CNY 23,329,490.77 in the previous year[5] - Cash inflow from operating activities totaled $452,604,819.01, slightly lower than $472,236,984.94, indicating a potential slowdown in revenue generation[22] - Cash flow from operating activities was ¥413,227,817.31, compared to ¥425,976,125.14 in the previous period[21] - Net cash flow from operating activities was $49,593,799.82, an increase from $23,329,490.77 in the previous period, reflecting a positive trend in operational efficiency[22] - Cash inflow from investment activities decreased significantly to $133,197,058.27 from $350,462,070.49, indicating a reduction in investment recovery[22] - Cash outflow for employee compensation was $40,258,285.95, up from $38,713,193.13, indicating a focus on talent retention and compensation[22] - The company reported a net cash flow decrease of $167,190,362.98, compared to a smaller decrease of $52,306,855.75 in the previous period, highlighting cash management challenges[23] Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,644,300,092.61, a 5.32% increase from CNY 3,460,279,665.56 at the end of the previous year[5] - Total current assets increased from ¥2,517,288,396.14 to ¥2,572,679,261.77, an increase of about 2.2%[14] - Total liabilities increased to ¥1,412,944,314.81 from ¥1,252,432,403.36, marking a growth of 12.8%[18] - The company's total liabilities increased, with accounts payable rising by 9.52% to CNY 468,879,680.27 from CNY 428,132,971.57[9] - Short-term borrowings increased from ¥167,759,758.60 to ¥233,371,755.53, a rise of about 39.1%[15] Shareholder Information - Total number of common shareholders at the end of the reporting period is 12,354[11] - The largest shareholder, Jiangsu Shangkun Biological Equipment Co., Ltd., holds 29.08% of shares, totaling 34,890,248 shares[11] - The number of shares held by the top 10 unrestricted shareholders includes 5,877,463 shares held by Yangzhong Financial Holdings Group Co., Ltd.[11] Expenses - The company reported a significant increase in sales expenses, which rose by 30.72% to CNY 1,982,511.98 from CNY 1,516,602.18[9] - Research and development expenses increased to ¥18,289,005.13 from ¥16,815,813.82, indicating a growth of 8.7%[19] Other Financial Metrics - The weighted average return on equity fell to 1.03%, down from 1.69% in the previous year[5] - Deferred income tax liabilities rose significantly to ¥2,394,705.30 from ¥571,146.57, an increase of 318.5%[18] - The company received government subsidies amounting to CNY 212,473.38, which are closely related to its normal business operations[6] - The company's cash and cash equivalents decreased from ¥880,380,086.42 to ¥718,402,321.38, a decline of approximately 18.4%[14] - Total cash and cash equivalents at the end of the period stood at $435,758,414.05, down from $662,690,779.29, indicating a decrease in liquidity[23] Audit Information - The company did not conduct an audit for the first quarter report, which may affect stakeholder confidence in financial reporting[24]
通灵股份(301168) - 2025 Q1 - 季度财报